These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23557616)

  • 61. Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan.
    Minai OA; Arroliga AC
    South Med J; 2006 Aug; 99(8):880-3. PubMed ID: 16929886
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
    Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
    Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients.
    De Santo LS; Mastroianni C; Romano G; Amarelli C; Marra C; Maiello C; Galdieri N; Della Corte A; Cotrufo M; Caianiello G
    Transplant Proc; 2008; 40(6):2015-8. PubMed ID: 18675118
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An evidence-based approach to the management of pulmonary arterial hypertension.
    Coyne TC
    Curr Opin Cardiol; 2006 Sep; 21(5):526; author reply 526-7. PubMed ID: 16900019
    [No Abstract]   [Full Text] [Related]  

  • 65. Dramatic response of a patient with pregnancy induced idiopathic pulmonary arterial hypertension to sildenafil treatment.
    Taçoy G; Ekim NN; Cengel A
    J Obstet Gynaecol Res; 2010 Apr; 36(2):414-7. PubMed ID: 20492398
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Treatment with oral sildenafil in patients with severe pulmonary hypertension after open heart operations].
    Zeng R; Zhuang J; Cen JZ; Chen XX; Xiong WP; Zhu WZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):916-9. PubMed ID: 16266481
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].
    Xiong CM; He JG; Lu XL; Shan GL; Wu BX; Zhu XY; Wu GH; Zeng XF; Guo T; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Tian HY; Li WM; Zhang DZ; Zhang C; Li MT; Liu HM; Guo YJ; Shen JY; Zhang WJ; Liu S; Zhou DX; Bao CD; Huang SA; Chen JY; Wu WF; Huang K; Li CL; Wang LH; He B
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):370-4. PubMed ID: 21418907
    [TBL] [Abstract][Full Text] [Related]  

  • 68. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
    Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment.
    Hall SM; Davie N; Klein N; Haworth SG
    Eur Respir J; 2011 Oct; 38(4):851-60. PubMed ID: 21406517
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pulmonary arterial hypertension associated with neurofibromatosis type 1.
    Carrascosa MF; Larroque IC; Rivero JL; García JA; Hoz MC; Ares MA; López XA; Caviedes JR
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22798089
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sildenafil citrate for the treatment of pulmonary hypertension.
    Hrometz SL; Shields KM
    Drugs Today (Barc); 2006 Dec; 42(12):771-84. PubMed ID: 17285150
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
    Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
    Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
    Stehlik J; Movsesian MA
    J Card Fail; 2009 Feb; 15(1):31-4. PubMed ID: 19181291
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy.
    Hill NS; Preston IR; Roberts KE
    Chest; 2008 Aug; 134(2):221-223. PubMed ID: 18682450
    [No Abstract]   [Full Text] [Related]  

  • 76. [Specific drugs for the treatment of pulmonary arterial hypertension - current status].
    Stähler G
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S183-6. PubMed ID: 18814092
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ophthalmic features of retinitis pigmentosa in Cohen syndrome caused by pathogenic variants in the VPS13B gene.
    Nasser F; Kurtenbach A; Biskup S; Weidensee S; Kohl S; Zrenner E
    Acta Ophthalmol; 2020 May; 98(3):e316-e321. PubMed ID: 31580008
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.
    Wang YW; Lin HC; Yang YY; Hou MC; Lee SD
    J Gastroenterol; 2006 Jun; 41(6):593-7. PubMed ID: 16868809
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
    Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N
    Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study.
    Frantz RP; Durst L; Burger CD; Oudiz RJ; Bourge RC; Franco V; Waxman AB; McDevitt S; Walker S
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):550-7. PubMed ID: 24742768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.